By Marisa Taylor Dr. Alan Green’s patients travel from around the country to his tiny practice in Queens, N.Y., lured by the prospect of longer lives. Over the past two years, more than 200 patients have flocked to see Dr. Green after learning that two drugs he prescribes could possibly stave off aging.
Lilly has released Lispro, a generic form of its insulin drug of Humalog, cutting the list price in half and ideally reducing out-of-pocket patient costs. Insulin Lispro will go for $137.35 per vial or $265.50 for a pack of five KwikPens. Because Humalog and Lispro are fast-acting forms of insulin,
By Shefali Luthra Democrats with 2020 presidential aspirations are courting the party’s increasingly influential progressive wing and staking out ambitious policy platforms. Front and center are three words: Medicare. For. All. That simple phrase is loaded with political baggage, and often accompanied by vague promises and complex jargon. Different candidates use
By Judith Graham About 25 million Americans who are aging in place rely on help from other people and devices such as canes, raised toilets or shower seats to perform essential daily activities, according to a new study documenting how older adults adapt to their changing physical abilities. But a substantial
By Eric Taub If the scores of personal health care devices at the Consumer Electronics Show in January are any indication, it’s clear that the Apple Watch has kicked off a rush by high-tech companies to capitalize on people’s worries about their health. The latest version of the watch, which was